Andrew Dudum - 23 Feb 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum
Issuer symbol
HIMS
Transactions as of
23 Feb 2026
Net transactions value
$0
Form type
4
Filing time
25 Feb 2026, 16:16:21 UTC
Previous filing
16 Dec 2025
Next filing
13 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dudum Andrew Chief Executive Officer, Director, 10%+ Owner 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum 25 Feb 2026 0001837796

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Award $0 +794,002 +90% $0.000000 1,672,734 23 Feb 2026 Direct F1
holding HIMS Class A Common Stock 384,731 23 Feb 2026 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 508,030 23 Feb 2026 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 791,117 23 Feb 2026 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 186,723 23 Feb 2026 Held by Trustee of AD 2025 GRAT dated 5-27-2025
holding HIMS Class A Common Stock 47,524 23 Feb 2026 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 2,214,769 23 Feb 2026 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
holding HIMS Class A Common Stock 1,080,972 23 Feb 2026 Held by Trustee of Dudum Legacy 2021 Trust
holding HIMS Class A Common Stock 3,004,071 23 Feb 2026 Held by Trustee of Dudum Family 2021 Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award had been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.